PUBLISHER: The Insight Partners | PRODUCT CODE: 1206338
PUBLISHER: The Insight Partners | PRODUCT CODE: 1206338
The Middle East & Africa GMP testing service market is expected to grow from US$ 41.84 million in 2022 to US$ 58.64 million by 2028; it is estimated to grow at a CAGR of 5.8% from 2022 to 2028.
Adoption of GMPs in R&D to Boost Middle East & Africa GMP Testing Service Market Growth in Coming Years
Research and development (R&D) are fundamentally an important phase of preproduction activities. The former revolves around a planned experiment to review, analyze, and revise the accepted or established principles, and draw conclusions or rectify already known facts of knowledge if required. However, in the latter phase, the results of former activities are checked in practical application scenarios to check their reproducibility in the production phase by developing new or improved products. Although the performance of a product under investigation is often unknown or not optimized, compliance with the GMPs is critical for ensuring the safety and efficacy of investigational medicines. Notebook reviews, spot inspections, and varied training programs, among other methods, are used to ensure better compliance in analytical laboratories, wherein investigational medicines are tested before their release for clinical use. As electronic systems such as laboratory information management system (LIMS), electronic databases, and data acquisition software are an integral part of scientists' work, they must be capable of the proper utilization of these systems. Notebook documentation, analytical instrumentation logs (calibration records and cross-references), method execution, laboratory operations, and electronic records are pivotal to ensuring GMPs. The compliance of all key actions and documents is assessed against current expected departmental work practices, instrument operating procedures (IOPs), and standard operating procedures (SOPs), and the findings are captured on standard forms. Thus, R&D departments are focusing on the use of IOPs and SOPs in their operations to avoid excessive monetary spending. Ensuring GMP compliance in R&D activities is essential to avoid product recalls, as it takes years to develop a product; product recalls may incur huge losses to manufacturers. Moreover, by opting for GMP testing services in R&D, companies can carry out proper research activities and develop products according to the needs of the GMP testing services market. Thus, the growing adoption of GMPs in R&D activities is expected to create notable opportunities for the growth of the Middle East & Africa GMP testing service market during the forecast period.
Middle East & Africa GMP Testing Service Market Overview
The United Arab Emirates (UAE), Saudi Arabia, and South Africa are the three major countries in the Middle East and South Africa. Saudi Arabia is the largest market for GMP testing services in this region in 2021. The GMP testing service market in the Middle East & Africa is anticipated to grow at a CAGR of 5.8% during the forecast period; this growth is attributed to the rising healthcare expenditure and increasing government initiatives in terms of funding and healthcare-related policies. Due to limited access to developed technologies in the healthcare, biotechnology, and pharmaceutical industries, the GMP testing service market is growing steadily in the rest of the Middle East and African countries.
Middle East & Africa GMP testing service Market Revenue and Forecast to 2028 (US$ Million)
Middle East & Africa GMP testing service Market Segmentation
The Middle East & Africa GMP testing service market is segmented on the basis of service type, end user, and country. Based on service type, the Middle East & Africa GMP testing service market is segmented into product validation testing, bioanalytical services, packaging & shelf-life testing, and other services type. The product validation testing segment held the largest market share in 2022.
Based on end user, the Middle East & Africa GMP testing service market is bifurcated into pharmaceutical and biopharmaceutical companies and medical device companies. The pharmaceutical and biopharmaceutical companies segment held a larger market share in 2022.
Based on country, the Middle East & Africa GMP testing service market is segmented into Saudi Arabia, South Africa, UAE, and the Rest of Middle East & Africa. The Rest of Middle East & Africa dominated the market share in 2022.
Eurofins Scientific; Almac Group; INTERTEK GROUP PLC; WuXi AppTec; Sartorius AG; Nelson Laboratories, LLC.; and Thermo Fisher Scientific Inc. (PPD Inc.) are among the leading companies operating in the Middle East & Africa GMP testing service market.